On August 26th, Shandong Sito Bio-Technology (300583.SZ) released its semi-annual report for 2024. During the reporting period, the total operating revenue was 0.567 billion yuan, a decrease of 14.62% year-on-year. The net income attributable to shareholders of the listed company was 13.2114 million yuan, a decrease of 77.97% year-on-year. After deducting non-recurring gains and losses, the net income attributable to shareholders of the listed company was 5.05 million yuan, a decrease of 86.40% year-on-year. The basic earnings per share were 0.07 yuan.
赛托生物(300583.SZ)：上半年净利润1321.14万元，同比下降77.97%
Shandong Sito Bio-Technology (300583.SZ): The net income in the first half of the year was 13.2114 million yuan, a year-on-year decrease of 77.97%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated